Jazz Pharmaceuticals (JAZZ) Shares Issued (2010 - 2026)

Jazz Pharmaceuticals has reported Shares Issued for 17 years, with the latest figure at $32.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 186.09% year-over-year to $32.9 million; the trailing twelve-month figure through Mar 2026 stood at $129.3 million (up 308.38% YoY), and the FY2025 full-year result was $107.9 million, up 422.41% from the prior year.
• Shares Issued for Q1 2026 stood at $32.9 million, down from $85.2 million in the prior quarter.
• The five-year high for Shares Issued was $85.2 million in Q4 2025, with the low at $17000.0 in Q3 2024.
• Average Shares Issued over 5 years is $18.0 million, with a median of $10.9 million recorded in 2024.
• Year-over-year, Shares Issued slumped 99.69% in 2024 and surged 4211.76% in 2025.
• Tracing JAZZ's Shares Issued over 5 years: stood at $30.2 million in 2022, then slumped by 70.64% to $8.9 million in 2023, then rose by 3.87% to $9.2 million in 2024, then jumped by 826.34% to $85.2 million in 2025, then plunged by 61.38% to $32.9 million in 2026.
• The last three Shares Issued figures came in at $32.9 million (Q1 2026), $85.2 million (Q4 2025), and $733000.0 (Q3 2025), per Business Quant data.

Peer Comparison